logo

Axonics Modulation Technologies, Inc. (AXNX)



Trade AXNX now with
  Date
  Headline
7/27/2020 6:04:32 AM Axonics Announces 2-Year Topline Clinical Results From ARTISAN-SNM Pivotal Study
7/13/2020 6:08:19 AM Axonicsn Sees Q2 Preliminary Net Revenue To Be $15.2 Mln
7/1/2020 4:03:45 PM Axonics Receives FDA Approval For 3T Full-Body MRI Scans
6/3/2020 6:05:22 AM Axonics: FDA Approves New Wireless Patient Remote Control With SmartMRI Technology
5/19/2020 6:11:00 AM Axonics Modulation Technologies Announces Publication Of The 1-year Results From Its ARTISAN-SNM Study
5/7/2020 9:36:17 PM Axonics Prices Public Offering Of 4 Mln Shares At $32.50/shr
4/29/2020 6:09:47 AM Axonics Modulation Technologies Appoints Michael Carrel As Chairman Of The Board
4/14/2020 6:04:43 AM Axonics: FDA Approves Next Generation Rechargeable Implantable Neurostimulator For Its R-SNM(r) System
4/6/2020 6:08:07 AM Axonics Modulation Submits PMA Supplement To FDA To Expand Full-Body MRI Labeling For 3T Scans
1/21/2020 6:03:22 AM Axonics Modulation Technologies Reports FDA Approval Of Enhanced Neurostimulator Programmer
1/9/2020 6:03:24 AM Axonics Modulation Technologies Reports Preliminary Revenue Of $10 Mln For Q4
12/19/2019 6:03:17 AM Axonics Says Granted 6 US Patents And Allowed 3 Addl Patents Related To Implantable Sacral Neuromodulation Technology
12/2/2019 6:16:02 AM Axonics Modulation Tech Says Health Canada Approves Full-Body MRI Labeling For Axonics R-SNM System
11/22/2019 4:36:38 PM Axonics Announces Closing Of $110 Mln Public Offering Of Common Stock
11/21/2019 6:03:58 AM Axonics Agrees To Supply The Axonics R-SNM System To University Of Tennessee Medical Center In Knoxville
11/19/2019 9:30:10 PM Axonics Modulation Prices Public Offering Of 5 Mln Shares At $22.00/shr
11/19/2019 4:04:24 PM Axonics Announces Proposed Public Offering Of Common Stock
11/14/2019 6:05:30 AM Axonics(r) Announces FDA Approval For Sacral Neuromodulation System For Urinary Clinical Indications
11/5/2019 6:11:19 AM Axonics Says Prepared To Act Quickly And Defend Itself Aggressively Medtronic Patent Lawsuit